Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Irma Rahayu Latarissa,1,2 Miski Aghnia Khairinisa,1 Ghina Nadhifah Iftinan,2 Anna Meiliana,1,3 Ida Paulina Sormin,4,5 Melisa Intan Barliana,6,7 Keri Lestari1,2,7 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Medication Therapy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Latarissa IR, Khairinisa MA, Iftinan GN, Meiliana A, Sormin IP, Barliana MI, Lestari K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2025-01-01
coleção:	Clinical Pharmacology: Advances and Applications
Assuntos:	randomized controlled trial quinine sulfate atovaquone artemisin-piperaquine sars-cov-2.
Acesso em linha:	https://www.dovepress.com/efficacy-and-safety-of-antimalarial-as-repurposing-drug-for-covid-19-f-peer-reviewed-fulltext-article-CPAA
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!